Axsome Therapeutics (AXSM) Gross Margin (2022 - 2026)
Axsome Therapeutics (AXSM) recorded Gross Margin of 93.79% in Q2 2026, up 2.75 percentage points from 91.04% a year earlier and up 1.49 percentage points from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Gross Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Axsome Therapeutics' Gross Margin came in at 93.24% as of Jun 30, 2026, up 1.76 percentage points year-over-year; for FY2025, it came in at 92.56%, up 1.20 percentage points from FY2024.
- Annual Gross Margin has increased for three straight years, with a three-year change of +2.95 percentage points (FY2022 to FY2025).
- Across earlier years, Gross Margin came in at 91.37% in FY2024 (+1.00 pp), 90.37% in FY2023 (+0.76 pp) and 89.61% in FY2022.
- The Q2 2026 figure is the highest quarterly Gross Margin in data going back to Q2 2022.
- On a year-over-year basis, Gross Margin has increased for nine consecutive quarters, with an average year-over-year change of +1.51 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 3.25 percentage points in Q3 2024, against a drop of 0.91 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 92.30% (Q1 2026), 93.71% (Q4 2025) and 93.03% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Axsome Therapeutics | 10.14 Bn | 8.87 Bn | 204.81 Mn | 93.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.79% |
| Mar 31, 2026 | 92.30% |
| Dec 31, 2025 | 93.71% |
| Sep 30, 2025 | 93.03% |
| Jun 30, 2025 | 91.04% |
| Mar 31, 2025 | 91.94% |
| Dec 31, 2024 | 91.15% |
| Sep 30, 2024 | 91.95% |
| Jun 30, 2024 | 90.76% |
| Mar 31, 2024 | 91.60% |
| Dec 31, 2023 | 89.69% |
| Sep 30, 2023 | 88.70% |
| Jun 30, 2023 | 90.15% |
| Mar 31, 2023 | 92.01% |
| Dec 31, 2022 | 90.60% |
| Sep 30, 2022 | 88.58% |
| Jun 30, 2022 | 88.85% |
API Access
Axsome Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();